Ask what the Affordable Care Act is, and the answer that matters most is structural: the Affordable Care Act is not one statute but two. Public Law 111-148, the Patient Protection and Affordable Care Act, laid the architecture in March 2010, and Public Law 111-152, the Health Care and Education Reconciliation Act of 2010, amended it one week later the companion passage-history article. That is the two-statute rule, and it is the namable claim on which this guide turns. Anyone who understands the Affordable Care Act can say, without hesitation, which of the two statutes did what, and can point to the right title of the statute for the insurance rules, the coverage subsidies, the Medicaid expansion, the financing taxes, and the delivery-system reforms.

The One Test for this guide is exactly that. After reading it, a reader should be able to state that the Affordable Care Act is two statutes rather than one, name what each statute did, and locate each of the five machines in its proper title. The insurance market rules sit in Title I. The coverage subsidies, the exchanges, the premium tax credits, and the shared-responsibility requirements sit in Title I as well, in the subtitles that build the coverage machinery. The Medicaid expansion sits in Title II. The financing taxes sit in Title IX. The delivery-system reforms, aimed chiefly at Medicare payment and quality, sit in Title III. A reader who can place all five has passed the test. A reader who treats the law as a single undifferentiated mass has not.

The two-statute rule deserves emphasis because the reconciliation act did more than polish the first statute. The Health Care and Education Reconciliation Act rewrote the financing provisions, changed the Medicaid terms, and rewrote the federal student loan provisions through amendments to the Higher Education Act of 1965. Its Title I carried the coverage, Medicare, Medicaid, and revenue changes, and its Title II carried the education and health changes. When later summaries describe the Affordable Care Act as a single law, they describe the two statutes read together, which is how Congress itself presented them: the reconciliation act combined with the Patient Protection and Affordable Care Act to form the health care reform law, in the words of the Congressional Research Service.

The confusion is understandable, and the One Test is designed to cut through it. The first statute runs 906 pages across ten titles and amends three different titles of the United States Code, and its provisions phase in on different schedules, with the consumer protections of sections 2711 to 2719 taking effect six months after enactment while the guaranteed issue and community rating rules of sections 2701 to 2709 waited for plan years beginning on or after January 1, 2014. The second statute then rewrote key parts of the first before the ink was dry. A reader armed only with the phrase health reform will drown in that complexity. A reader armed with the two-statute rule and the five-machine map will not, because every provision in the law answers to one of two questions: which statute enacted it, and which machine does it serve.

A practical way to apply the One Test is to quiz the locator instinct directly. Where do the insurance rules live? Title I, in the Public Health Service Act sections. Where do the coverage subsidies live? Title I as well, in the exchange and affordability subtitles, with their tax-code anchors in Title 26. Where does the Medicaid expansion live? Title II, in the Social Security Act amendments. Where do the financing taxes live? Title IX, as modified by the reconciliation act. Where do the delivery-system reforms live? Title III, aimed at Medicare. Five questions, five answers, and the two-statute rule governing all of them: the first statute built the machines, and the second statute rewrote the financing, the Medicaid terms, and the student loan provisions before the first had been in force a month.

This section covers the opening of the guide: the statutory identity of the two laws, the five machines that organize their provisions, and the first machine, the insurance market rules that bind insurers whether or not a subsidy is involved. Later sections of the guide take up the coverage machinery, the Medicaid expansion, the financing, and the delivery-system reforms in turn. Nothing here argues for or against the policy. The contested claims about the law are reported as the claims of their named makers, and each side of the dispute gets its strongest case.

The statute has a precise identity, and precision matters because loose citations are the usual source of confusion. The Patient Protection and Affordable Care Act is Public Law 111-148, 124 Stat. 119, enacted by the 111th Congress and signed by President Barack Obama on March 23, 2010. It traveled through Congress as H.R. 3590, a House bill that the Senate adopted as its vehicle for health reform; the Senate passed it on December 24, 2009, by a vote of 60 to 39, and the House agreed to the Senate version on March 21, 2010, by a vote of 219 to 212. One week later came the second statute. The Health Care and Education Reconciliation Act of 2010 is Public Law 111-152, signed on March 30, 2010, enacted from H.R. 4872. The House passed it on March 21 by 220 to 211; the Senate, after striking two provisions on education grants, passed it on March 25 by 56 to 43; and the House concurred in the Senate amendments that same evening by 220 to 207. Read together, as Congress directed, the two statutes form the law known as the Affordable Care Act.

The codification map shows how the two statutes distributed their work across the existing codes. The vehicle deserves a sentence of its own, because it explains a persistent point of confusion. H.R. 3590 began life as the Service Members Home Ownership Tax Act of 2009, introduced by Representative Charles Rangel on September 17, 2009. The Senate adopted it as its legislative vehicle for health reform and substituted the health care text in its entirety, which is why a bill with an unrelated original title became the Patient Protection and Affordable Care Act. The House then passed its own health bill on November 7, 2009, by 220 to 215, but the Senate version is the one that became law: passed by the Senate on December 24, 2009, by 60 to 39, and agreed to by the House on March 21, 2010, by 219 to 212. The insurance market rules amended the Public Health Service Act, where they appear at 42 U.S.C. sections 300gg and following, renumbering and adding to the market-reform provisions that had been in place since the Health Insurance Portability and Accountability Act of 1996. The coverage and financing machinery amended the Internal Revenue Code, including the premium tax credit at 26 U.S.C. 36B, the employer shared-responsibility payments at 26 U.S.C. 4980H, and the individual shared-responsibility payment at 26 U.S.C. 5000A. The public-program provisions amended the Social Security Act, the same act that carries Medicare and Medicaid, the two programs created by the Social Security Amendments of 1965. And the group-health-plan rules amended the Employee Retirement Income Security Act of 1974, ERISA, so that the insurance standards reach employer-sponsored coverage through the labor title as well as the public-health title. A researcher looking for the market rules opens the Public Health Service Act; a researcher looking for the tax credits and the shared-responsibility payments opens the Internal Revenue Code; a researcher looking for the Medicaid expansion opens the Social Security Act. That is the map.

The Affordable Care Act in Five Machines

The cleanest way to read the Affordable Care Act is as five machines that do five different jobs, plus a remainder of provisions that do not fit any of the five. The five are the insurance market rules, the coverage machinery, the Medicaid expansion, the financing, and the delivery-system reform. Each machine lives in a distinct title of the statute, which is why the title map is the reader’s best tool. Keep the map in hand and the 906 pages of Public Law 111-148 stop looking like a wall.

The first machine, the insurance market rules, is the subject of the next section of this guide. It lives in Title I of Public Law 111-148, in the new and renumbered sections 2701 to 2719A of the Public Health Service Act. These rules bind health insurance issuers directly, regardless of whether the person buying the policy receives a subsidy. Guaranteed issue, community rating, the ban on preexisting condition exclusions, the ban on lifetime and annual limits on essential health benefits, dependent coverage to age twenty-six, preventive services without cost sharing, and the medical loss ratio all belong to this machine. The machine changes what an insurer may do when it sells a policy, not how the policy is paid for.

The second machine is the coverage machinery, also in Title I, in the subtitles that create the health insurance exchanges, the premium tax credits, the cost-sharing reductions, and the shared-responsibility requirements for individuals and employers. Subtitle D establishes the exchanges where individuals and small businesses shop for standardized coverage, and Subtitle E builds the affordability structure around them: the premium tax credit at 26 U.S.C. 36B, available to eligible households between 100 and 400 percent of the federal poverty level who purchase through an exchange, and the cost-sharing reductions of section 1402, which lower out-of-pocket spending for households in the same income band. The essential health benefits package of section 2707 defines the floor of what exchange plans must cover. The premium tax credit at 26 U.S.C. 36B and the employer responsibility payments at 26 U.S.C. 4980H are the tax-code anchors of this machine, and the individual requirement at 26 U.S.C. 5000A is its companion. The employer provisions apply to applicable large employers, generally those with fifty or more full-time employees, and impose assessable payments when such an employer fails to offer coverage and at least one full-time employee receives a premium credit through an exchange. The logic of the machine is that the market rules of the first machine cannot stand alone: if insurers must accept every applicant and may not price on health status, the coverage must be made affordable and the risk pool must be broadened. Supporters of the law, including President Obama, presented this three-part structure as the answer to adverse selection, the tendency of insurance markets to attract the sickest buyers when the healthy stay out. Whether that structure works as designed is contested, and the guide reports the dispute without resolving it.

The third machine is the Medicaid expansion, and it lives in Title II, titled The Role of Public Programs. Title II expands Medicaid eligibility to low-income adults, strengthens support for the Children’s Health Insurance Program, simplifies Medicaid and CHIP enrollment, and adjusts the federal-state financing arrangements, including the payments to hospitals that serve a disproportionate share of low-income patients. The reconciliation act then modified several of these Medicaid terms, including the federal matching rates that determine how much of the expansion cost Washington bears. This machine reaches people through the public programs rather than through private insurance, which is why it sits in its own title, and it is the machine that most directly continues the work of the 1965 amendments: the same Social Security Act, the same joint federal-state structure, a new population brought inside it.

The fourth machine is the financing, and it lives in Title IX, titled Revenue Provisions, as modified by the reconciliation act’s Title I Subtitle E. Title IX supplies the individual shared-responsibility payment at 26 U.S.C. 5000A and the employer shared-responsibility payments at 26 U.S.C. 4980H, alongside other new taxes and fees on the health sector. The Congressional Budget Office and the staff of the Joint Committee on Taxation estimated that the two statutes together would reduce federal budget deficits by $143 billion over the 2010 to 2019 period, with $124 billion of that from the health care provisions. That estimate is an analysis, not a fact about the future, and opponents of the law disputed its assumptions; the guide states the estimate as CBO’s and leaves the argument where it belongs.

The fifth machine is the delivery-system reform, and it lives in Title III, titled Improving the Quality and Efficiency of Health Care. Title III is aimed chiefly at Medicare: linking payment to quality outcomes, encouraging new patient-care models, improving the Medicare Part D prescription drug benefit and narrowing the gap in its coverage known as the doughnut hole, adjusting payments to Medicare Advantage plans, and funding research on comparative effectiveness. The theory behind this machine, as its supporters described it, is that the way the government pays for care shapes the care that is delivered, so changing the payment rules changes the delivery system.

Then there is the remainder, the provisions that belong to none of the five machines but that a complete guide must still name. Title IV, on prevention of chronic disease and improving public health, includes section 4205, which requires chain restaurants and similar retail food establishments with 20 or more locations to post calorie information on menus and menu boards. Title V addresses the health care workforce. Title VI, on transparency and program integrity, includes section 6002, the Physician Payments Sunshine Act, which requires drug and device manufacturers to report payments and transfers of value to physicians and teaching hospitals; the provision was originally introduced in 2007 by Senators Chuck Grassley and Herb Kohl. Title VII, on improving access to innovative medical therapies, carries the Biologics Price Competition and Innovation Act, which created an abbreviated approval pathway for biosimilar biological products. Title VIII created the Community Living Assistance Services and Supports Act, a voluntary long-term care insurance program. And Title X, titled Strengthening Quality, Affordable Health Care for All Americans, is the amendment title: it revises and supplements the nine titles that came before it, which is where several of the market-rule refinements and effective-date changes landed.

The dispute over the law, stated at its strongest on each side, runs through all five machines. Supporters, led by President Obama, argued that the market rules would end the practices of denying coverage for preexisting conditions and imposing lifetime limits, that the coverage machinery and the Medicaid expansion would extend insurance to millions of uninsured Americans, that the delivery-system reforms would begin to tie payment to quality, and that the whole package would reduce the deficit as CBO estimated. Opponents, led by Senate Minority Leader Mitch McConnell, argued that the federal requirements and the taxes would raise insurance costs and the cost of doing business, that the individual requirement was an improper exercise of federal power over personal economic decisions, and that the Medicaid expansion would strain state budgets and federal finances. The guide does not adjudicate between these positions. It describes what the statute does, attributes each argument to the side that made it, and leaves the reader to judge.

The table below summarizes the five machines and the non-insurance remainder in a single map, matching each machine to its title, its principal statutory anchors, and the population it reaches.

Machine	Provisions that build it	Entity bound	Funding source	Series article carrying the detail
Insurance market rules	Title I; Public Health Service Act sections 2701 to 2719A (42 U.S.C. 300gg and following)	Health insurance issuers and group health plans	No new federal outlay; compliance cost borne by issuers	The key-provisions article
Coverage machinery	Title I; sections 1311, 1321, and 1402; 26 U.S.C. 36B, 5000A, and 4980H	Individuals, applicable large employers, and exchange operators	Premium tax credits and cost-sharing reductions from general revenue	The key-provisions article
Medicaid expansion	Title II; Social Security Act 1902(a)(10)(A)(i)(VIII) and 1905(y)	States, as a condition of continued Medicaid participation	100 percent federal match for 2014 through 2016, phasing to a permanent 90 percent floor	The Medicaid statute structure article
Financing	Title IX; 26 U.S.C. 3101(b)(2), 1411, 4191, and 5000B	High earners, health insurers, drug and device makers	New taxes and fees plus slower Medicare payment growth	The key-provisions article
Delivery-system reform	Title III; Social Security Act 1115A, 1866D, 1886(o), and 1886(q); sections 3021, 3022, 3025, 3403, and 6301	Medicare providers, hospitals, and accountable care organizations	Savings retained by Medicare; mandatory innovation-center funding	The CMS Medicare rulemaking article
Non-insurance remainder	Titles IV through VIII and X; the biosimilars pathway (Title VII), the Sunshine Act (section 6002), menu labeling (section 4205)	Drug and device makers, chain restaurants, physicians, and teaching hospitals	Prevention and Public Health Fund; industry compliance costs	The health legislation since 1950 article

The First Machine: Insurance Market Rules That Bind Every Insurer

The first machine is the set of insurance market rules in Title I of Public Law 111-148, added to the Public Health Service Act as sections 2701 to 2719A and codified at 42 U.S.C. sections 300gg and following. These provisions renumber and extend the market reforms that Congress first enacted in the Health Insurance Portability and Accountability Act of 1996, which had added the earlier versions of sections 2701 to 2722 to the same act. These rules are the part of the law that an insurer feels whether or not the person buying the policy gets a tax credit. They regulate the sale of health insurance itself: who must be sold a policy, what the premium may be based on, what the policy must cover, and how much of the premium must be spent on care. Seven provisions do most of the work, and a reader who understands these seven understands the machine.

Guaranteed issue comes first, at section 2702 of the Public Health Service Act, codified at 42 U.S.C. 300gg-1. Every health insurance issuer that offers coverage in the individual or group market in a state must accept every employer and every individual in the state that applies for the coverage. That is the whole of the rule in one sentence, and it is the sentence that ended medical underwriting in the individual market. The statute permits the issuer to channel enrollment through open enrollment periods and special enrollment periods for qualifying events, and it permits network plans to limit applicants to those who live, work, or reside in the plan’s service area, but it does not permit the issuer to turn away an applicant because the applicant is sick, has been sick, or is likely to become sick.

What does guaranteed issue require of insurers?

Section 2702 requires every insurer selling individual or group coverage in a state to accept every employer and individual that applies. Issuers may channel enrollment through annual open enrollment periods and special enrollment periods for qualifying events such as losing other coverage. The rule bars refusal based on health status or medical history.

Community rating comes second, at section 2701, codified at 42 U.S.C. 300gg. With respect to the premium rate charged for coverage offered in the individual or small group market, the rate may vary only by whether the plan covers an individual or a family, by the rating area or geography, by age, with variation for adults limited to a ratio of 3 to 1, and by tobacco use, with variation limited to a ratio of 1.5 to 1. The rate may not vary by any other factor. That closing clause is doing the heavy lifting: health status, medical history, claims experience, gender, and occupation may not be used in setting the premium. The statute further provides that the age and tobacco variations in family coverage are applied based on the portion of the premium attributable to each family member. The rating rules govern the individual and small group markets; the statute adds a special rule for a state that permits large group issuers to offer coverage through its exchange, in which case the provisions apply to all coverage offered in that market in the state other than self-insured group health plans. Community rating is what makes guaranteed issue financially coherent as a pair: the first rule says the insurer must sell to everyone, and the second says the insurer may not price the sick out of the market it has been required to enter.

The ban on preexisting condition exclusions is section 2704, codified at 42 U.S.C. 300gg-3. Group health plans and issuers in the individual and group markets may not exclude coverage for preexisting health conditions. The provision took effect for enrollees under age nineteen six months after enactment, on September 23, 2010, and for all other enrollees it took effect for plan years beginning on or after January 1, 2014. Before this rule, an insurer could accept an applicant and then refuse to pay for the very condition the applicant most needed treated; the statute closes that door. The related provision at section 2705 prohibits discrimination against individual participants and beneficiaries based on health status, so that eligibility rules cannot be used to do indirectly what section 2704 forbids directly.

The ban on lifetime and annual limits is section 2711. A group health plan or an issuer offering group or individual coverage may not establish any lifetime limit, or any annual limit, on the dollar amount of essential health benefits for any individual, whether the benefits are provided in network or out of network. The statute permits limits on specific covered benefits that are not essential health benefits, to the extent otherwise allowed by federal or state law, but the core protection is categorical: a policy may not cap what it will pay over a lifetime, or over a year, for the benefits the law defines as essential. This provision, like the preexisting condition ban, addresses the fear that animated much of the support for the market rules, the fear of a family learning that a serious illness had exhausted the policy. The ban on annual limits phased in: for plan years beginning before January 1, 2014, the statute permitted restricted annual limits that the Secretary of Health and Human Services defined by regulation, and the full prohibition applied from 2014 onward.

Dependent coverage to age twenty-six is section 2714. A group health plan or an issuer offering group coverage that makes dependent coverage of children available must make that coverage available for children until the child attains twenty-six years of age. The terms of the coverage may not vary based on the age of the child, except for children twenty-six or older, and the plan may not impose additional eligibility conditions on the adult child, such as student status or marital status. The rule does not require a plan to cover the child of a child receiving dependent coverage. Of the market rules, this one took effect earliest for most families, applying to plan years beginning six months after enactment.

Preventive services without cost sharing is section 2713. A group health plan or an issuer offering group or individual coverage must provide coverage for specified preventive services and may not impose any cost-sharing requirements, such as a copayment, coinsurance, or deductible, for them. The covered services are those with a rating of A or B in the current recommendations of the United States Preventive Services Task Force, routine immunizations recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, and, for infants, children, adolescents, and women, the preventive care and screenings in the comprehensive guidelines supported by the Health Resources and Services Administration. The provision is a coverage mandate and a pricing mandate at once: the services must be covered, and they must be covered free of out-of-pocket cost to the patient. Grandfathered plans are exempt from the preventive services rule, one of the lines the statute draws between coverage that existed at enactment and coverage issued afterward.

The medical loss ratio rule is section 2718, titled Bringing Down the Cost of Health Care Coverage. It requires health insurance issuers to report annually to the Secretary of Health and Human Services on how premium dollars were spent, and it sets a floor on the share of premium revenue that must go to clinical services and activities that improve health care quality rather than to administration, marketing, and profit. The floor is 85 percent in the large group market and 80 percent in the small group and individual markets. An issuer whose ratio falls below the applicable floor must pay rebates to policyholders. The rule is the machine’s answer to the question of what happens to the premium dollar after the sale: the market rules govern the sale, and the medical loss ratio governs the accounting.

How does the medical loss ratio rule work?

Section 2718 sets a floor on how much of each premium dollar must go to clinical care and quality improvement. Issuers in the large group market must reach 85 percent; those in the small group and individual markets must reach 80 percent. Issuers that fall short owe rebates to policyholders.

Several companion rules complete the machine and deserve brief notice. Section 2703 requires guaranteed renewability: an issuer that offers coverage in the individual or group market must renew it at the option of the plan sponsor or the individual. Section 2708 prohibits waiting periods longer than ninety days. Section 2712 prohibits rescissions, the retroactive cancellation of coverage, except in cases of fraud or intentional misrepresentation of material fact, and requires advance notice to the enrollee. Section 2719 establishes internal claims and appeals and external review processes, and section 2719A sets patient protections for choice of health care professional and coverage of emergency services. Section 2715 requires a uniform explanation of coverage documents and standardized definitions so that shoppers can compare plans. Together with the seven principal provisions, these rules form a single regulatory fabric: the insurer must sell to all comers, must price on a short list of permitted factors, must cover the essential benefits without dollar caps or health-based exclusions, must keep adult children on family policies to twenty-six, must cover preventive care without cost sharing, and must spend the required share of premiums on care or rebate the difference.

The machine did not switch on all at once, and the phasing is part of understanding it. The consumer protections added by sections 2711 to 2719, including the bans on lifetime and annual limits and rescissions, the extension of dependent coverage, and the preventive services rule, applied to plan years beginning six months after enactment, on September 23, 2010. The market reforms added by sections 2701 to 2709, including guaranteed issue, community rating, the preexisting condition ban for adults, and guaranteed renewability, applied to plan years beginning on or after January 1, 2014. Plans in which a person was enrolled on the date of enactment, known as grandfathered plans, were permitted to remain essentially the same, but even they had to comply with selected rules, including the extension of dependent coverage to age twenty-six, the elimination of annual and lifetime limits, and the prohibition on rescissions. The grandfathered concept was the statute’s transitional bargain: existing coverage would not be forcibly rewritten overnight, while the core protections would reach even those who kept their old plans.

Several of the market rules apply to health insurance issuers rather than to self-insured employer plans, a boundary the statute draws repeatedly. The medical loss ratio and community rating provisions regulate the business of insurance, while the bans on lifetime limits and preexisting condition exclusions reach group health plans directly. The distinction matters because a large share of American workers are covered by self-insured employer plans that bear their own risk, and the first machine touches those plans through the plan-facing rules rather than the issuer-facing ones.

The contested arguments about this machine are worth stating plainly because the machine is the part of the law that touches every insured American. Supporters, including President Obama, argued that these rules ended the worst documented abuses of the individual market: denial of coverage to the sick, dollar caps that left the seriously ill uninsured in all but name, and the pricing of women and older applicants out of the market. Opponents, including Senate Minority Leader McConnell, argued that requiring insurers to accept all applicants while restricting how they price would raise premiums for the young and healthy, concentrate costs, and drive insurers from the least profitable markets. Each side’s strongest case turns on the same mechanism viewed from opposite ends: the rules redistribute the cost of illness across the whole risk pool, which is either the point of insurance or a distortion of it, depending on who is describing it. The statute itself takes the supporters’ view of the mechanism and the opponents’ view nowhere; the guide reports both views and adopts neither.

The Second Machine: Exchanges, Credits, and the Coverage Requirement

The act’s central coverage provisions, introduced in the companion overview of the act’s key provisions, work as an interlocking set of parts rather than as a single command. The insurance market reforms establish who must be sold coverage and on what terms, but those rules alone do not put a policy in anyone’s hands. A second machine carries people toward enrollment: organized marketplaces where coverage can be compared and purchased, tax credits and cost-sharing assistance that lower the price, a coverage requirement backed by a tax penalty, and rules pressing large employers to keep offering workplace plans. Each part has its own statutory home, and each is calibrated to the others.

The marketplaces are the visible entry point. Section 1311 of the act directs each state to establish, no later than January 1, 2014, an American Health Benefit Exchange that facilitates the purchase of qualified health plans. The same section provides for a Small Business Health Options Program, known as a SHOP Exchange, designed to help qualified small employers in the state enroll their workers in plans offered in the small group market. A state may merge its individual and SHOP operations into a single exchange if the combined operation has adequate resources to serve both populations. The statute gives states latitude in how they build these entities: an exchange may be operated as a governmental agency or as a nonprofit entity, subject to standards set by the Secretary of Health and Human Services.

Congress anticipated that some states would not build their own marketplaces, and it supplied a federal backstop. Section 1321 directs the Secretary of Health and Human Services to issue regulations setting standards for the establishment and operation of exchanges, the offering of qualified health plans, and related programs. States elect to apply those federal standards or equivalent state standards by 2014. If a state is not an electing state, or if the Secretary determines that an electing state will not have a required exchange operational by January 1, 2014, then section 1321(c) requires the Secretary to establish and operate an exchange within that state. The practical result is a system in which every state is covered by an exchange, whether state-built or federally facilitated. Under the statute, the initial open enrollment period runs from October 1, 2013, through March 31, 2014, and exchanges must begin offering coverage to qualified individuals and small businesses on January 1, 2014.

Exchanges perform several functions beyond listing plans. They certify which plans may be sold as qualified health plans, they screen applicants for eligibility for premium tax credits and cost-sharing reductions, and they serve as a front door to public coverage by routing applicants who qualify toward Medicaid or the Children’s Health Insurance Program. The statute also directs exchanges to operate navigator programs that assist consumers in understanding their options, and to set up toll-free hotlines and maintain internet portals so that shoppers can compare plans on price, benefits, and quality. Enrollment through an exchange is limited to citizens and lawful residents of the United States; incarcerated individuals may not enroll through an exchange.

The products sold on exchanges are standardized around the qualified health plan. A qualified health plan is offered by a state-licensed insurer, is certified by the exchange as meeting the statutory criteria, covers the essential health benefits package, and meets specified actuarial value and cost-sharing standards. Certification requires, among other things, that the plan not use marketing practices or benefit designs that discourage enrollment by people with significant health needs, that it maintain an adequate network of providers, and that it include essential community providers serving low-income and medically underserved populations where available. Because certification is tied to the exchange in the state where the plan is sold, a plan certified in one state is not automatically a qualified health plan in another.

Section 1302 defines the essential health benefits package that qualified health plans must carry. The statute directs the Secretary to define the package, subject to the requirement that it include at least ten general categories: ambulatory patient services; emergency services; hospitalization; maternity and newborn care; mental health and substance use disorder services, including behavioral health treatment; prescription drugs; rehabilitative and habilitative services and devices; laboratory services; preventive and wellness services and chronic disease management; and pediatric services, including oral and vision care. The package is required to be equal in scope to the benefits provided under a typical employer plan, and the act directed the Department of Labor to survey employer plans to inform that determination. The essential health benefits package also incorporates limits on cost sharing, and it applies not only to exchange plans but to nongrandfathered plans in the individual and small group markets generally, whether sold inside or outside the exchanges.

The metal tiers translate the benefits package into standardized levels of generosity. Section 1302(d) provides four levels, distinguished by actuarial value: bronze plans at approximately 60 percent, silver plans at approximately 70 percent, gold plans at approximately 80 percent, and platinum plans at approximately 90 percent. Actuarial value is an estimate of the share of total average costs for covered benefits that the plan will pay for a standard population; the remainder falls to the enrollee through deductibles, copayments, and coinsurance. A higher actuarial value therefore means lower cost sharing on average, and the tiers let shoppers compare plans on a common scale. The statute also provides a catastrophic tier available only to individuals under age 30 and to those qualifying for a hardship or affordability exemption, covering the essential health benefits with very high cost sharing except for a limited number of primary care visits.

The premium tax credit under 26 U.S.C. section 36B is the principal device that makes exchange coverage affordable for middle-income households. To be an applicable taxpayer, a household must file a federal income tax return, enroll in a qualified health plan through an individual exchange, and have household income of at least 100 percent but not more than 400 percent of the federal poverty level. Married taxpayers must file jointly. Individuals who are eligible for other qualifying coverage, such as Medicare, Medicaid, or an affordable employer-sponsored plan, generally do not qualify. The credit is refundable, so a household may claim the full amount even with little or no federal income tax liability, and it is advanceable: advance payments are made directly to the insurer on the household’s behalf, reducing monthly premiums as they come due, with a reconciliation against the actual credit on the annual tax return.

The credit amount is keyed to a benchmark. The statute measures the household’s expected contribution against the premium for the second-lowest-cost silver plan available in the household’s rating area, and the credit equals the difference between the benchmark premium and the expected contribution, capped at the premium of the plan the household actually selects. The expected contribution rises with income: the statute placed it at 2 percent of household income for families at 100 percent of the poverty level, rising on a sliding scale to 9.5 percent of income for families at 400 percent of the poverty level. Because the credit is calculated against the benchmark silver premium, a household that chooses a cheaper bronze plan pays less than its expected contribution, while a household that chooses a gold or platinum plan pays the extra cost itself.

How is the premium tax credit calculated for a household buying on an exchange?

The credit equals the difference between the premium for the second-lowest-cost silver plan in the household’s area and the household’s expected contribution, which rises from 2 percent of income at 100 percent of the poverty level to 9.5 percent at 400 percent. It is capped at the premium of the plan actually chosen.

Section 1402 adds a second layer of assistance for lower-income enrollees. Cost-sharing reductions are available to exchange enrollees with household incomes between 100 and 250 percent of the federal poverty level who also qualify for the premium tax credit and who enroll in a silver plan. Unlike the premium credit, cost-sharing reductions do not lower the monthly premium; they reduce what the enrollee pays when using care, by lowering deductibles, copayments, and coinsurance and by reducing the annual out-of-pocket maximum. In effect, cost-sharing reductions raise the actuarial value of a silver plan for eligible enrollees to approximately 73, 87, or 94 percent depending on income. The reductions are available only on silver plans, which gives lower-income shoppers a strong reason to select silver coverage even when a bronze plan carries a lower premium.

The exchange system serves a defined population that differs from the population served by Medicaid. Exchanges are built for individuals and families purchasing coverage on their own, including the self-employed and workers whose employers do not offer qualifying coverage, and for small employers buying through the SHOP program. Medicaid, by contrast, is a joint federal-state program covering specified low-income populations under its own eligibility rules, which the act expands for nonelderly adults up to 133 percent of the federal poverty level with an income disregard that effectively reaches 138 percent. A household too poor for the premium tax credits is generally expected to be covered through Medicaid in states implementing the expansion, while households above that line may buy on the exchange with credits. The legal boundary between the two programs, and the distinct legal characters of the public programs themselves, are explained in the companion article on the legal difference between Medicare and Medicaid.

The individual shared responsibility provision at 26 U.S.C. section 5000A supplies the coverage requirement. For taxable years beginning after December 31, 2013, individuals must maintain minimum essential coverage for themselves and their dependents or pay a penalty. Minimum essential coverage is defined broadly: it includes government-sponsored programs such as Medicare and Medicaid, eligible employer-sponsored plans, individual market plans including qualified health plans bought on an exchange, and grandfathered health plans. The requirement is therefore not a requirement to buy on an exchange; any of these forms of coverage satisfies it.

The penalty is collected through the tax system. It is reported on the individual’s annual federal income tax return and is calculated as the greater of a flat dollar amount or a percentage of household income above the tax filing threshold, phased in over three years. For 2014 the penalty is the greater of $95 or 1 percent of income; for 2015, the greater of $325 or 2 percent; for 2016, the greater of $695 or 2.5 percent, with the flat dollar amount indexed for inflation in later years. The monthly penalty is one-twelfth of the annual amount, multiplied by the number of months without coverage or an exemption. The flat amount is assessed per adult and at half the adult amount per child under 18, with the total flat amount for a family capped at 300 percent of the applicable adult amount, so $2,085 for a family in 2016. The total penalty in any year cannot exceed the national average premium for bronze-level plans offered through exchanges for the relevant family size.

The statute carves out extensive exemptions from the penalty. No penalty applies for months in which an individual cannot afford coverage, meaning the required contribution for the lowest-cost bronze plan or for an affordable employer plan exceeds 8 percent of household income. Other exemptions cover taxpayers whose income falls below the filing threshold, members of federally recognized Indian tribes, individuals experiencing a short coverage gap of less than three consecutive months, individuals granted hardship exemptions by the Secretary, members of religious sects conscientiously opposed to accepting insurance benefits, members of health care sharing ministries, incarcerated individuals, and individuals not lawfully present in the United States. The exemption structure means the penalty reaches, in the Treasury Department’s phrase from its proposed rules, a limited group of taxpayers who spend a substantial period without coverage despite having ready access to affordable coverage.

The employer shared responsibility provision at 26 U.S.C. section 4980H applies the other side of the coverage strategy. It reaches applicable large employers, defined as employers that employed an average of at least 50 full-time employees, including full-time equivalents, on business days during the preceding calendar year. For this purpose a full-time employee is one employed on average at least 30 hours of service per week. Part-time hours are combined into full-time equivalents solely for determining whether the employer crosses the 50-employee threshold; any penalty is calculated on full-time employees.

Two triggers can produce an assessable payment, and both depend on employees actually receiving exchange subsidies. Under section 4980H(a), if an applicable large employer fails to offer minimum essential coverage to its full-time employees and their dependents, and at least one full-time employee obtains a premium tax credit or cost-sharing reduction for exchange coverage, the employer owes an annual payment of $2,000 for each full-time employee, disregarding the first 30, prorated monthly. Under section 4980H(b), if the employer does offer coverage but the coverage is unaffordable to the employee or fails to provide minimum value, and at least one full-time employee obtains a premium tax credit or cost-sharing reduction, the employer owes $3,000 per year for each affected employee receiving the subsidy, with the total capped at the amount that would have been owed under the no-offer trigger. Both dollar amounts are indexed for calendar years after 2014. In this way the statute does not simply command employers to insure their workers; it prices the decision to leave workers dependent on subsidized exchange coverage.

These parts are commonly described as a three-legged stool, a characterization attributed to MIT economist Jonathan Gruber, who used the metaphor in an August 2010 memorandum during the design debate, and popularized by economists and policy analysts including Paul Krugman. The first leg is the market reform: guaranteed issue and community rating, which require insurers to sell to all comers and limit how much premiums may vary by health status. The second leg is the coverage requirement, the individual mandate, which draws people into the risk pool. The third leg is the system of subsidies, the premium tax credits and cost-sharing reductions, which make the required coverage affordable. Gruber’s argument was that the legs are structural rather than decorative: remove one and the design wobbles.

The mechanics of the stool turn on adverse selection. If insurers must cover everyone at similar prices, healthy people have an incentive to wait until they are sick before buying coverage, since the healthy year’s premium exceeds the healthy year’s expected medical costs. The people who do buy are disproportionately those who expect high medical spending, which raises average costs and premiums, which in turn drives more healthy people out. The mandate counters this by making it costly to remain uninsured, pulling healthier people into the pool and stabilizing average premiums. The subsidies perform the complementary function: they keep the cost of complying with the mandate within reach for households between 100 and 400 percent of the poverty level, so the mandate does not simply fine people who cannot afford what it demands.

Supporters and opponents of the design made sharply different cases about the mandate, and each side’s strongest argument deserves a hearing. The Obama administration and the act’s Democratic sponsors argued that the mandate was the linchpin of the market reforms: without a broad risk pool, guaranteed issue would trigger the premium spiral described above, and the coverage expansions the law promised would be financially unsustainable. On this view, the mandate was not an optional add-on but the condition that made the rest of the insurance regulation work. Republican critics in Congress and the Republican state attorneys general who filed suit in federal court in Florida on March 23, 2010, argued that the requirement exceeded Congress’s constitutional authority: they contended that compelling individuals to purchase a private product, on pain of a tax penalty, went beyond any prior exercise of the commerce power and intruded on state sovereignty. The administration’s response was that the requirement regulated participation in the health care market, in which virtually everyone eventually participates, and that precedent supported it.

Viewed as a whole, the second machine works through the decisions of the people it touches. A household shopping on an exchange sees plans standardized by metal tier and priced against a benchmark silver premium; the premium tax credit lowers the monthly bill and the cost-sharing reductions lower the price of care itself for those with the lowest incomes. The individual mandate raises the cost of staying out, while the exemptions keep the penalty from reaching those for whom coverage is genuinely unaffordable. Large employers face a parallel calculation under the shared responsibility rules, which attach a price to leaving full-time workers to seek subsidized exchange coverage. The exchanges, the credits, the mandates, and the employer rules are separate statutory provisions, but they were designed to turn together.

The Third Machine: The Medicaid Expansion as Enacted

The first two machines of the Patient Protection and Affordable Care Act, Public Law 111-148, rewrote the rules of private insurance and built the machinery of the exchanges. The third machine reached for a different lever, one that predated the law by forty-five years. Section 2001 of the act, headed “Medicaid Coverage for the Lowest Income Populations,” expanded the joint federal-state Medicaid program, the venture created under Title XIX of the Social Security Act, into the largest single source of new coverage the statute contemplated.

To understand what the expansion changed, it helps to recall what Medicaid had required before it. Historically, federal Medicaid eligibility had been limited to certain low-income children, pregnant women, parents of dependent children, the elderly, and individuals with disabilities. A poor adult without children, no matter how little that adult earned, generally had no path into the program in most states. The new law attacked that exclusion directly, and it did so not by creating a new program alongside Medicaid but by rewriting who Medicaid had to cover.

The centerpiece was a new mandatory eligibility group, codified as clause (VIII) of Section 1902(a)(10)(A)(i) of the Social Security Act. Beginning January 1, 2014, every state Medicaid plan had to cover individuals who were under age 65, not pregnant, not entitled to benefits under Medicare Part A or enrolled for benefits under Medicare Part B, not described in any other mandatory coverage group, and whose household income did not exceed 133 percent of the federal poverty level. The provision deliberately swept in the population the old categories had left out: nondisabled, nonelderly adults without dependent children, the group federal analysts expected to produce the greatest increase in enrollment under the law. The Social Security Administration’s 2011 legislative history of the program described the change in the same terms, noting that beginning in 2014 the act would extend eligibility to all individuals under age 65 in families with income below the new line, with no requirement of parenthood, disability, pregnancy, or age.

The number the statute printed was 133 percent, but the number that governed enrollment was 138 percent. The Senate bill had carried the 133 percent figure, which already served as the minimum federal standard for pregnant women and young children, while the House had favored 150 percent during its deliberations. Senate procedural rules made it difficult to alter the figure in the Senate-passed bill through reconciliation, so the Health Care and Education Reconciliation Act of 2010, Public Law 111-152, kept the 133 percent figure and added an income disregard equal to five percentage points of the federal poverty level. Applied through the modified adjusted gross income counting rules the act imposed for most eligibility groups, the disregard raised the effective threshold to 138 percent of the poverty level. The law expressly excluded from the new group anyone age 65 or older, anyone pregnant, anyone dually eligible for Medicare, and anyone already described in another mandatory coverage group, keeping those populations on their existing pathways.

As enacted, the expansion was mandatory, not optional. The statute made coverage of the new group a condition of continued participation in Medicaid, and the law’s enforcement machinery was the longstanding authority under Section 1904 of the Social Security Act permitting the Secretary of Health and Human Services to withhold federal Medicaid payments from a noncompliant state. In combination with that authority, the act as written put a state’s existing federal Medicaid funding at stake if the state refused to cover the new group. That is the design as enacted in 2010. Later litigation over the expansion falls outside this article’s scope; the companion article on NFIB v. Sebelius carries the case discussion.

Was the Medicaid expansion mandatory for states as enacted?

As enacted, the expansion was mandatory, not optional. It required every state plan to cover adults under age 65 with incomes up to 133 percent of the federal poverty level, effective January 1, 2014, as a condition of continued federal Medicaid funding. Later litigation over the expansion is beyond this article’s scope.

To induce states to accept the new obligation, the law offered an unusually generous federal match for the people it called “newly eligible.” A newly eligible individual was defined, in Section 1905(y) of the Social Security Act, as someone in the new group who would not have been eligible for full Medicaid benefits under the state’s plan or waiver rules in effect on December 1, 2009. For that population, the federal government would pay 100 percent of costs for calendar years 2014 through 2016, then 95 percent in 2017, 94 percent in 2018, 93 percent in 2019, and 90 percent for 2020 and every year after, a permanent floor far above the regular Medicaid matching rates, which were set by a formula in place since the program’s 1965 enactment and ranged from 50 percent to 73.4 percent depending on the state. States that had already expanded coverage on their own before the law, by covering parents and childless adults up to at least 100 percent of the poverty level when the act was enacted on March 23, 2010, received a separate transitional match, the “expansion state” rate, that rose gradually until it equaled the newly eligible rate in 2020. Seven states fell into that category: Arizona, Delaware, Hawaii, Massachusetts, Maine, New York, and Vermont. The design was plain: Washington would bear nearly the entire cost of the new enrollees, leaving states a fraction that grew only to one dollar in ten.

The expansion also changed what the new enrollees would receive. Rather than the traditional Medicaid benefit package, individuals in the new adult group were required to receive an alternative benefit plan, a benchmark plan modeled on commercial insurance coverage that had to include the ten essential health benefit categories the act specified. People with special medical needs were exempt from the alternative plan requirement, and states retained flexibility to add benefits, but the default design treated the new adults as a distinct population with a distinct package.

The expansion also reached backward into the Children’s Health Insurance Program. Children ages 6 through 18 in families with incomes up to 133 percent of the poverty level who had been enrolled in separate CHIP programs were to be transitioned into Medicaid, as were children who moved from CHIP to Medicaid through application of the 5 percent income disregard, and for both groups the law let states claim the higher CHIP matching rate on the affected expenditures.

Between enactment and 2014, the law froze the landscape in place. The maintenance-of-effort provisions, which extended and expanded similar rules from the 2009 stimulus law, required states to keep the Medicaid eligibility standards, methodologies, and procedures that had been in place on March 23, 2010 until the exchanges were operating for adults on January 1, 2014, and through September 30, 2019 for children under age 19, with a parallel requirement to maintain income eligibility levels for children in the Children’s Health Insurance Program through the same 2019 date. A state that imposed more restrictive rules risked the loss of all its federal Medicaid matching funds. The one safety valve the law provided was narrow: states facing a certified budget deficit could reduce eligibility for nondisabled adults above 133 percent of the poverty level. Supporters of the freeze, including the Obama administration, described it as a bridge to keep people covered until the new options opened; state officials who chafed at it argued it locked in spending during a fiscal crisis, and both readings appeared in the debate that followed enactment.

The new group entered each state’s program through the program’s ordinary legal instrument: the state plan amendment. Medicaid is administered through state plans, the written descriptions of each state’s program filed with and approved by the Centers for Medicare and Medicaid Services, and states implemented the act’s Medicaid changes by amending those plans. To ease the process, the agency prepared preprinted amendment templates covering the consolidation of eligibility categories, the new adult group, the new income-counting methods, and the administrative changes the law required of every state, whether or not the state embraced every new option. The state plan amendment was therefore the hinge on which the whole third machine turned: the statute set the national standard, and each state wrote that standard into its own plan, subject to federal approval, before the first newly eligible adult could enroll on January 1, 2014.

The statute did not make every state wait for 2014 to begin. Effective April 1, 2010, just days after enactment, states could elect to cover the new adult group early through a state plan amendment, covering the whole group at once or phasing in by income level. The catch was fiscal: the enhanced federal match did not begin until the coverage became mandatory in 2014, so early expanders received only their regular Medicaid matching rate in the interim. Connecticut became the first state to win approval from the Centers for Medicare and Medicaid Services for the early option, and several others, including California, the District of Columbia, Minnesota, New Jersey, and Washington, began moving adults into the new group ahead of 2014 through the state plan option or through demonstration waivers. For those states the early years were a down payment made at the regular match in exchange for experience enrolling a population many state agencies had never served.

The Congressional Budget Office’s March 2010 estimates gave the expansion its official scale. With the reconciliation amendments folded in, CBO and the Joint Committee on Taxation projected roughly 16 million additional Medicaid and Children’s Health Insurance Program enrollees by 2019, and federal Medicaid and CHIP outlays $434 billion higher over the 2010 through 2019 window than under prior law. State spending on the two programs would rise too, by about $26 billion over the same period, a figure CBO noted reflected states’ flexibility to make programmatic and other budgetary adjustments. The uninsured population, meanwhile, would fall by roughly 32 million nonelderly people by 2019. Those numbers made the expansion the single largest coverage provision in either statute, larger than the exchange subsidies, which CBO priced at $466 billion over the same decade.

The expansion was also the most contested piece of the law’s coverage machinery, and each side’s strongest case was on the table before the first enrollment card was printed. Supporters, led by the Obama administration, House Speaker Nancy Pelosi, and Senate Majority Leader Harry Reid, argued that only a public program could reach adults whom the private market had never served, that the 100 percent federal match for the first three years made the deal the most generous in Medicaid’s history, and that the 90 percent permanent floor left states paying a tenth of the cost of people who had previously arrived at emergency rooms uninsured and uncompensated. Opponents, led by House Minority Leader John Boehner and Senate Minority Leader Mitch McConnell, answered that even a tenth of a large expansion would strain state budgets, that the mandatory design and the maintenance-of-effort freeze stripped states of the flexibility to manage Medicaid during a fiscal crisis, and that a future Congress could always revisit the promised matching rates, leaving states holding a population they could not afford and could no longer drop. Governors and state Medicaid directors pressed a version of the same warning in more practical terms, pointing to the penalty for violating the maintenance-of-effort rules, the loss of all federal Medicaid matching funds, as evidence that the law left states little room to maneuver. The statute resolved none of those arguments; it simply set the mechanism, the match, and the date, and left the fighting to the years after 2011.

The Fourth Machine: Paying for It

Every coverage machine in the two statutes needed a fuel line, and the fourth machine was the law’s answer to the oldest objection in the debate: who pays. The Patient Protection and Affordable Care Act never traveled alone on this question. Its financing provisions were split between the original act and the Health Care and Education Reconciliation Act of 2010, Public Law 111-152, which amended, delayed, and in some cases created the revenue measures outright. The resulting package drew from three reservoirs at once: new taxes on high earners and investment income, fixed annual fees and excise taxes on the health industries, and reductions in the growth of Medicare payments. The Congressional Budget Office and the Joint Committee on Taxation, in their March 20, 2010 cost estimate of the two bills together, projected a net reduction in federal deficits of $143 billion over the 2010 through 2019 period, with $124 billion of that coming from the health care and revenue provisions and $19 billion from the education provisions. Supporters cited that score as proof the coverage expansion was paid for; critics, including House Budget Committee ranking member Paul Ryan and former CBO director Douglas Holtz-Eakin, charged that the estimate relied on budgetary gimmicks such as counting revenues that began years before the spending they financed. The dispute over the score ran parallel to the dispute over every tax and fee inside it, and each provision deserves its own accounting.

The heaviest single tax in the package fell on wages. The act imposed an additional hospital insurance tax of 0.9 percent on high-income workers, codified at 26 U.S.C. 3101(b)(2), applying to wages above $200,000 for individuals filing as single or head of household, above $250,000 for married couples filing jointly, and above $125,000 for married individuals filing separately. The tax took effect for taxable years after December 31, 2012, and it applied only to the employee’s share, with no employer match, raising the hospital insurance portion of the payroll tax from 1.45 percent to 2.35 percent on earnings above the thresholds while leaving the rate on earnings below them untouched. Employers were required to begin withholding the additional amount once an employee’s wages passed $200,000, even though an individual employee’s actual liability depended on total household earnings, a wrinkle the Internal Revenue Service addressed in guidance to employers and payroll administrators. The Joint Committee on Taxation projected the provision would raise $86.8 billion over ten years, with the proceeds flowing to the Medicare Hospital Insurance Trust Fund. The thresholds were not indexed to inflation, a design choice critics of the tax seized on: as nominal wages rose over time, more earners would drift above the fixed lines and into the surtax.

A second tax, added outright by the reconciliation act rather than the original statute, fell on investment income. New Section 1411 of the Internal Revenue Code imposed a 3.8 percent tax on the lesser of a taxpayer’s net investment income or the amount by which modified adjusted gross income exceeded the same thresholds, $200,000 for individuals, $250,000 for joint filers, and $125,000 for married filers filing separately. Like the payroll surtax it took effect for taxable years beginning after December 31, 2012, and like that tax its thresholds were not indexed to inflation. The design was precise: a taxpayer with no investment income owed none of the tax no matter how far modified adjusted gross income exceeded the line, while a taxpayer whose entire income came from investments owed it only on the lesser amount. Supporters of the pair, including the Obama administration, described them as asking the highest earners to contribute to an expansion from which they would benefit least directly; opponents, including Boehner and McConnell, argued that taxing wages and investment returns at the margin would discourage work, saving, and the capital formation on which job growth depended, and that the unindexed thresholds amounted to a slow-motion tax increase on the middle class as inflation did its work.

The industries the law expected to gain millions of new paying customers were asked to pay for the privilege. Section 9010 of the act imposed a fixed annual fee on the health insurance sector, and Section 1406 of the reconciliation act rewrote its schedule: $8 billion in 2014, $11.3 billion in 2015 and 2016, $13.9 billion in 2017, and $14.3 billion in 2018, with the amount for later years set at the preceding year’s total increased by the rate of premium growth. The fee was nondeductible for federal income tax purposes and was divided among covered insurers according to each company’s share of net premiums written, with employers, governmental entities, small insurers, and certain nonprofit insurers serving low-income, elderly, or disabled populations excluded from the calculation. The insurance industry’s trade association, America’s Health Insurance Plans, fought the fee as a tax on coverage itself, arguing that insurers would pass the cost through to policyholders in the form of higher premiums, a charge the American Action Forum’s analysis supported when it estimated the law’s taxes and fees would add several hundred dollars a year to premiums for exchange plans. Defenders of the fee answered that insurers stood to gain millions of subsidized customers through the exchanges and the Medicaid expansion, and that a fee scaled to market share was a fair price for that windfall.

The branded drug makers faced a parallel levy. Section 9008, as amended by Section 1404 of the reconciliation act, imposed a fixed annual fee on manufacturers and importers of branded prescription drugs, including biological products and excluding orphan drugs, with the aggregate amount set by statute: $2.5 billion in 2011, $2.8 billion in each of 2012 and 2013, $3 billion in each year from 2014 through 2016, $4 billion in 2017, $4.1 billion in 2018, and $2.8 billion in 2019 and every year after. Each company’s share was allocated according to its portion of branded drug sales to specified government programs, and the proceeds were directed to the Medicare Supplementary Medical Insurance trust fund. The Joint Committee on Taxation projected the fee would raise $27 billion over ten years. The drug industry’s strongest objection mirrored the insurers’: the fee would be folded into prices and borne by patients and payers. The provision’s defenders replied that the industry’s products would reach millions of newly insured patients, and that a market-share fee captured part of that gain for the public that created it.

Medical device makers received an excise tax rather than a fee. Section 1405 of the reconciliation act scrapped the original statute’s planned industry fee and replaced it with a new Section 4191 of the Internal Revenue Code: a 2.3 percent excise tax on the sale price of taxable medical devices sold by manufacturers, producers, or importers, applying to sales after December 31, 2012. Eyeglasses, contact lenses, hearing aids, and devices of a type generally purchased by the public at retail for individual use were excluded, as were sales for export and sales of devices used in further manufacturing. Unlike the insurer and drug fees, the device tax was deductible for federal income tax purposes. The Joint Committee on Taxation projected it would raise $20 billion over ten years. Device manufacturers argued that the tax would fall on an industry of small and mid-sized innovators, raise the cost of everything from pacemakers to artificial joints, and cost American jobs; supporters of the tax answered that device makers, like drug makers and insurers, would sell into a larger insured market, and that a 2.3 percent levy on the sale price was modest against that expansion.

The most politically charged revenue provision aimed not at an industry but at a feature of the tax code itself. Section 9001 of the act, the provision known as the Cadillac tax, imposed a 40 percent excise tax on high-cost employer-sponsored health coverage, effective for taxable years beginning after December 31, 2017, which made January 1, 2018 the first effective date as enacted. The tax applied to the value of coverage exceeding $10,200 a year for individual coverage and $27,500 a year for family coverage, counting employer and employee premium contributions together with contributions to health savings accounts, health reimbursement arrangements, and flexible spending accounts, with the thresholds indexed to the Consumer Price Index in later years. The tax was imposed on the coverage provider, typically the insurer or, for self-insured employers, the plan administrator, and as enacted it was not deductible from the provider’s gross income. The provision’s logic, as its proponents in the administration and among health economists described it, was behavioral as much as fiscal: the unlimited exclusion of employer health benefits from income and payroll taxes encouraged overly generous plans that insulated workers from the cost of care and fed the overuse of low-value services, and a 40 percent tax on the excess value would push employers and workers toward leaner coverage, with much of the revenue arriving indirectly through higher taxable wages rather than through the excise tax itself. Its opponents made the mirror-image case with equal force: labor unions and employer groups argued the tax punished workers for benefits they had negotiated in lieu of wages, that plans crossed the thresholds for reasons having nothing to do with generosity, such as older or sicker workforces and high local medical costs, and that the Consumer Price Index indexing guaranteed the tax would reach further into ordinary plans each year because health costs had always grown faster than general inflation. The Congressional Budget Office and the Joint Committee on Taxation predicted that roughly three quarters of the provision’s budgetary effect would arrive indirectly, through higher income and payroll taxes as workers shifted toward less costly plans and took more compensation as wages, rather than through excise taxes collected from insurers.

Medicare itself supplied a large share of the financing through slower payment growth rather than new taxes. Section 3201 of the act restructured payments to Medicare Advantage plans, the private plans that contract with Medicare to cover beneficiaries. Payments were frozen at 2010 levels for 2011, and beginning in 2012 county benchmarks were tied to per capita fee-for-service spending: counties in the highest quartile of fee-for-service spending received benchmarks set at 95 percent of that spending, the second quartile at 100 percent, the third at 107.5 percent, and the lowest quartile at 115 percent, with the transition phased in over two, four, or six years depending on how far each county’s benchmark had to fall. Quality bonuses added up to five percentage points to benchmarks for highly rated plans, doubled in certain qualifying counties, and benchmarks were capped at the levels they would have reached without the law. The design embodied a judgment its authors stated openly: in high-spending counties, private plans should be able to deliver Medicare’s benefits for less than fee-for-service Medicare cost, and the program should not pay them more than that cost. The provision’s defenders argued the old benchmarks had overpaid plans relative to traditional Medicare; plan sponsors and their allies argued the cuts would force plans to trim extra benefits and raise cost sharing for the seniors who had chosen them.

Smaller levies filled out the package. The law imposed a 10 percent excise tax on indoor tanning services, raised the income threshold for itemizing out-of-pocket medical expenses from 7.5 percent to 10 percent of adjusted gross income, and increased the additional tax on health savings account withdrawals not used for qualified medical expenses from 10 percent to 20 percent, with a parallel increase for Archer medical savings accounts from 15 percent to 20 percent. Each was modest on its own; together they signaled the breadth of the search for offsets, reaching from tanning salons to the tax treatment of medical spending.

One financing provision had nothing to do with health care at all, and the two-statute structure is the reason it sat in a health law. Title II of the reconciliation act, the Student Aid and Fiscal Responsibility Act, ended new lending under the Federal Family Education Loan program: no new FFEL loans could be made after June 30, 2010, and every new federal student loan would originate through the Direct Loan program, in which the Treasury supplied the capital directly. The Congressional Budget Office estimated the switch would save $61 billion over ten years by eliminating the subsidies and guarantees the government had paid private lenders, with part of the savings redirected to Pell Grants. The provision’s inclusion was a matter of legislative arithmetic rather than policy kinship: reconciliation rules let the student loan savings count toward the same budget score as the health provisions, and supporters presented the two titles as a single exercise in redirecting federal subsidies from middlemen to beneficiaries.

Taken together, the financing provisions were the law’s answer to the charge that it spent without paying, and the charge never went away. The administration and its congressional allies, Pelosi and Reid among them, pointed to the Congressional Budget Office’s $143 billion deficit-reduction score and to a design in which high earners, profitable health industries, and Medicare overpayments bore the cost of covering tens of millions of uninsured people. Boehner, McConnell, Ryan, Holtz-Eakin, and the industries facing the fees answered that scores assumed what Congress would later be tempted to undo, that taxes on investment and on the inputs of care would be passed through to workers, patients, and premium payers, and that a law financed by a dozen levies nobody had voted for in isolation was paid for only in the most technical sense. Both cases were argued from the same Congressional Budget Office tables. The law’s authors had made their wager: that the revenue would arrive, the score would hold, and the coverage would follow.

The Fifth Machine: Changing How Care Is Delivered

The insurance provisions of the Affordable Care Act drew the headlines, but the law contained a second, quieter project in its third title, devoted to improving the quality and efficiency of health care. That title did not expand coverage or regulate insurers. It rewrote how Medicare pays for medical services, on the premise held by the law’s authors that the way the federal government buys care shapes the care that gets delivered. The title created a permanent innovation laboratory, a program for organized groups of providers, two hospital payment programs, a national pilot for bundled payments, a nonprofit institute for comparing treatments, and an independent board charged with holding down Medicare spending growth. It also closed the most conspicuous hole in the Medicare prescription drug benefit.

The programs in this section shared a common diagnosis. Medicare paid for each service separately, which rewarded volume over coordination. It paid hospitals without regard to the quality of the care they delivered. And it paid for drugs without comparing the alternatives. Each provision below tried, in a different way, to change what the payment rewarded.

Section 3021 added section 1115A to the Social Security Act, creating the Center for Medicare and Medicaid Innovation within the Centers for Medicare and Medicaid Services. The statute charged the center with testing innovative payment and service delivery models to reduce program expenditures while preserving or enhancing the quality of care furnished to beneficiaries, language drawn directly from section 3021(a). The models could touch Medicare and Medicaid, including the Children’s Health Insurance Program. The center was to begin carrying out its duties not later than January 1, 2011, consulting with federal agencies and outside clinical and analytical experts and seeking public input through open-door forums and other mechanisms. The statute gave preference to models that improved the coordination, quality, and efficiency of care for people entitled to Medicare Part A or Part B or eligible for Medicaid. If testing showed that a model reduced spending without reducing quality, or improved quality without increasing spending, the Secretary could expand the model, including on a nationwide basis, through the notice-and-comment rulemaking process that governs Medicare payment changes.

Section 3021 also gave the center unusual follow-through power. If the Secretary determined, through the center’s testing, that a model either reduced spending without reducing quality or improved quality without increasing spending, the Secretary could expand the model’s duration and scope through rulemaking, and the statute barred administrative and judicial review of the decisions to select, test, evaluate, or expand a model. The provision thus combined a testing laboratory with a mechanism for taking successful experiments to national scale without a second act of Congress. The act provided the center with 5 million dollars in mandatory funding for fiscal year 2010 for design, implementation, and evaluation of models, and 10 billion dollars for the activities initiated under the section for the period of fiscal years 2011 through 2019, with the amounts to remain available until expended.

Section 3022 directed the Secretary to establish the Medicare Shared Savings Program no later than January 1, 2012. Under the program, groups of providers and suppliers known as accountable care organizations could continue to receive traditional fee-for-service payments under Medicare Parts A and B while becoming eligible for additional payments if they met specified quality and savings requirements. To participate, an organization had to agree to be accountable for the quality, cost, and overall care of the Medicare fee-for-service beneficiaries assigned to it, enter into an agreement with the Secretary lasting at least three years, maintain a legal structure capable of receiving and distributing shared-savings payments, and include enough primary care professionals to serve at least 5,000 assigned beneficiaries. The statute recognized several eligible groupings: professionals in group practice arrangements, networks of individual practices, partnerships or joint ventures between hospitals and professionals, hospitals employing professionals, and any other group the Secretary deemed appropriate. The design borrowed from integrated delivery systems in which physicians, rather than insurers, coordinated care across the full continuum of services, with the aim of reducing costs and improving quality at the same time.

What does an accountable care organization have to do to earn shared savings?

The organization must be assigned at least 5,000 Medicare fee-for-service beneficiaries, enter a three-year agreement with the Department of Health and Human Services, meet statutory governance and leadership requirements, and satisfy the quality performance standards that the Secretary establishes before it can receive a share of any Medicare savings.

The mechanics turned on a benchmark. The Centers for Medicare and Medicaid Services would calculate a benchmark from each ACO’s historical per-beneficiary spending under Parts A and B, and savings would be measured as the difference between that benchmark and actual spending. The ACO would receive a share of the difference only if it also cleared the quality performance standards the Secretary established; an organization that saved money but missed the quality marks forfeited its share.

Section 3025 added section 1886(q) to the Social Security Act, establishing the Hospital Readmissions Reduction Program for hospital discharges beginning October 1, 2012. Under the program, Medicare reduces payments to hospitals with excess readmissions, comparing each hospital’s risk-adjusted readmission rate with the national average. A readmission, for the program’s purposes, means an admission to a hospital within 30 days of a discharge from the same or another hospital. The statute began with three conditions: acute myocardial infarction, heart failure, and pneumonia. The payment adjustment reached beyond the readmission cases themselves, reducing a hospital’s payments across its Medicare cases. The statute capped the penalty at 1 percent of base payments in fiscal year 2013, 2 percent in fiscal year 2014, and 3 percent in fiscal year 2015 and each year after. Certain hospitals, including critical access hospitals and specialty hospitals, sat outside the program. The measure carried out a recommendation the Medicare Payment Advisory Commission had made in its 2007 and 2008 reports to Congress, where the commission urged lawmakers to authorize a program that would penalize hospitals for excess readmissions of Medicare fee-for-service enrollees.

Section 3001 added section 1886(o) to the Social Security Act, establishing the Hospital Value-Based Purchasing Program for discharges on and after October 1, 2012. Under the program, the Secretary sets performance standards, develops a methodology for assessing hospitals, and assigns each participating hospital a performance score each fiscal year based on achievement or improvement relative to those standards. Hospitals that meet or exceed the standards receive value-based incentive payments. In a deliberate design choice, the incentive payments are financed from within the hospital payment system rather than from new money: the statute requires a reduction in each hospital’s base operating diagnosis-related-group payment, set at 1 percent in fiscal year 2013 and rising to 2 percent by fiscal year 2017, with the withheld pool redistributed as incentive payments. The program thus moves money among hospitals on the basis of measured quality. In its January 2011 proposed rule, the Centers for Medicare and Medicaid Services suggested evaluating hospitals for the first year on 17 clinical process-of-care measures and eight measures from the Hospital Consumer Assessment of Healthcare Providers and Systems survey, which records patients’ experience of inpatient care. The program’s machinery sits within the broader statutory framework for how Medicare pays hospitals under Parts A and B.

The scoring system rewarded both excellence and progress. A hospital earned points for achievement relative to national benchmarks and for improvement over its own baseline performance, with the higher of the two scores counting toward its total. The statute thus gave low-performing hospitals a reason to improve and high-performing hospitals a reason to stay at the top, since incentive payments depended on the score rather than on a fixed threshold.

Section 3403 created the Independent Payment Advisory Board, a 15-member body whose explicit statutory charge was to reduce the per capita rate of growth in Medicare expenditures. Beginning in 2013, the Chief Actuary of the Centers for Medicare and Medicaid Services was to calculate the projected five-year average growth in Medicare per capita spending alongside a target growth rate. If the projection exceeded the target, the actuary would establish an applicable savings target and the board would be required to submit a proposal reducing Medicare spending by at least that amount, transmitting it to the President and Congress by January 15. The statute set the targets in advance: 0.5 percent of total Medicare outlays in 2015, 1 percent in 2016, 1.25 percent in 2017, and 1.5 percent in 2018 and each year after. The law fenced the board’s discretion with prohibitions. It could not recommend rationing health care, raising revenues, increasing beneficiary premiums or cost sharing, restricting benefits, or changing Medicare eligibility rules. Board proposals would receive fast-track consideration in Congress, and only Congress, acting through the procedures the statute provided or by passing alternative legislation achieving equivalent savings, could stop them. If the board failed to submit a qualifying proposal, the Secretary of Health and Human Services was required to submit one in its place. The board was among the law’s most contested creations. Senator John Rockefeller of West Virginia, one of the provision’s architects, said the board was designed to reduce the influence of special interests on Medicare payment policy, arguing that those interests had kept Congress from making difficult spending decisions. House Budget Committee Chairman Paul Ryan charged that the board would ration care for seniors, describing it as an unelected body with binding power over Medicare. The board’s defenders answered that the statute expressly barred rationing, benefit restrictions, and eligibility changes. The mechanism was designed to trigger only when spending growth exceeded the statutory targets, forcing proposals for savings that Congress would then have to confront or replace.

The board’s 15 members were to be appointed by the President with Senate confirmation and serve staggered six-year terms, with the President required to consult congressional leaders of both parties on most of the nominations. The fast-track procedures were the provision’s teeth. The statute set firm deadlines for committee and Senate floor consideration of the implementing legislation and limited the amendment process, compressing the normal congressional calendar. Congress retained two exits: it could pass alternative legislation achieving the same savings, or it could discontinue the automatic process through a separate fast-track mechanism the law also created.

Section 3023 added section 1866D to the Social Security Act, creating a national pilot program on payment bundling. Under the pilot, the Secretary could test payment for an episode of care provided around a hospitalization, combining services such as the inpatient stay, physicians’ services, and post-acute care into a single bundled payment instead of paying each provider separately. The statute directed the Secretary to select the medical conditions for the pilot, up to 10 conditions under section 10308 of the act, which raised the number from eight, and to run the program for five years. The Secretary could extend the pilot for participating providers if the Secretary found that the extension improved quality or left it unreduced while reducing spending under the program. The pilot’s premise was that linking payment to an episode rather than to individual services would give providers a shared financial interest in coordinating care and avoiding complications.

Section 6301 established the Patient-Centered Outcomes Research Institute as a nonprofit corporation charged with assisting patients, clinicians, purchasers, and policymakers in making informed health decisions by advancing the quality and relevance of evidence about preventing, diagnosing, treating, monitoring, and managing health conditions. The institute’s core work was comparative effectiveness research: comparing drugs, medical devices, tests, surgeries, and methods of delivering care to determine which interventions worked best, for which patients, and under what circumstances. Congress funded the institute through a new Patient-Centered Outcomes Research Trust Fund under section 9511 of the Internal Revenue Code, financed in part by annual fees on health insurers and sponsors of self-insured health plans. The fees applied to policy and plan years ending after September 30, 2012, set at two dollars per covered life, and one dollar per covered life for years ending before October 1, 2013. The statute placed boundaries on the research enterprise it created. It provided that the institute would not develop a dollars-per-quality-life-year estimate as a threshold for establishing recommended care, and that its findings could not be construed as mandates or recommendations for payment, coverage, or treatment decisions.

The institute was to be governed by a board of governors drawn from patients, clinicians, researchers, and other stakeholders, with a separate methodology committee setting the scientific standards for the research it funded. The directors of the Agency for Healthcare Research and Quality and the National Institutes of Health were to serve on the board, reflecting the institute’s roots in the comparative effectiveness work those agencies had long pursued.

Section 3301 confronted the coverage gap in the Part D prescription drug benefit created by the 2003 Medicare law, the stretch of the benefit in which enrollees paid the full cost of their prescriptions after their initial coverage was exhausted and before catastrophic coverage began. The provision created the Medicare Coverage Gap Discount Program, codified at 42 U.S.C. 1395w-114a, under which the Secretary was to enter agreements with drug manufacturers requiring them to provide 50 percent discounts on brand-name drugs dispensed to beneficiaries in the gap, beginning in 2011. Manufacturers that wanted their drugs covered under Part D had to participate. Beneficiaries who fell into the gap in 2010 received a one-time rebate of 250 dollars instead. The statute then scheduled the gap’s phaseout: the beneficiary’s share of drug costs in the gap would fall each year until it reached 25 percent in 2020 for both brand-name and generic drugs, matching the standard cost sharing that applied outside the gap. Because the manufacturer discounts counted toward beneficiaries’ true out-of-pocket spending, the discount program also moved enrollees through the gap more quickly even before the gap closed.

Beyond Insurance: The Rest of the Statute

The provisions collected in this section share no policy in common except their vehicle. Each rode to enactment inside a statute universally described as health insurance reform, and each operates with no connection to insurance markets, exchanges, subsidies, or coverage mandates. A law remembered for insurance also rewrote drug approval pathways, restaurant menus, and physician payment disclosure.

The pattern was not accidental. Major health legislation has long carried provisions to the finish line inside the largest available vehicle. The provisions below show how far beyond insurance this particular vehicle reached.

Title VII of the act, comprising sections 7001 through 7003, is the Biologics Price Competition and Innovation Act. Before it, the Food and Drug Administration had no abbreviated route for approving follow-on versions of biological products. The Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, had created an abbreviated pathway for small-molecule generics, which are chemically identical to their brand-name counterparts and can prove equivalence through bioequivalence studies. Biologics are different. They are grown in living cells, and no two manufacturing runs produce a molecule that is identical in every respect, so a copy can be highly similar to the original without being the same. The generic pathway did not fit the science, and Congress had never built a biologics equivalent.

Title VII amended section 351(k) of the Public Health Service Act to create that equivalent: an abbreviated licensure pathway for biological products shown to be biosimilar to, or interchangeable with, an FDA-licensed reference product. A biosimilar applicant must show, through analytical, animal, and clinical studies, that the product is highly similar to the reference product with no clinically meaningful differences in safety, purity, and potency, and that it uses the same mechanism of action, route of administration, dosage form, and strength. An interchangeable product faces a higher bar. The applicant must also show that the product can be expected to produce the same clinical result in any given patient and that alternating between the products carries no greater risk than continued use of the reference product. The distinction matters because interchangeability, unlike mere biosimilarity, opens the door to pharmacy-level substitution.

Title VII also built a distinctive patent-dispute process. Before a biosimilar reached the market, the biosimilar applicant and the reference product sponsor were to exchange lists of relevant patents and negotiate which patents would be litigated first, a choreographed sequence that adapted the Hatch-Waxman patent provisions to biologics, where the patents were often more numerous and the products harder to characterize. The process gave the originator a structured chance to defend its intellectual property while giving the biosimilar applicant a defined path to market.

The act paired the new pathway with long protections for the originator. A reference biologic receives 12 years of data exclusivity from first licensure, a biosimilar application cannot even be submitted until four years after the reference product’s approval, and the first product approved as interchangeable with a given reference product receives one year of exclusivity against later interchangeables. Supporters of the pathway argued that biosimilar competition would hold down prices for some of the most expensive therapies in medicine. The Biotechnology Industry Organization defended the 12-year exclusivity period as the protection originator companies needed to justify the investment behind products that take many years to develop. Both sides received part of what they sought: a competitive pathway where none had existed, and one of the longest exclusivity periods in American drug law.

Section 6002 added section 1128G to the Social Security Act, known as the Physician Payments Sunshine Act. It does not ban or limit any payment. It requires applicable manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the Children’s Health Insurance Program to report payments or other transfers of value to physicians and teaching hospitals, and it requires manufacturers and group purchasing organizations to report physician ownership or investment interests. The reports are annual, filed with the Department of Health and Human Services, and published on a searchable public website, with the first reports due March 31, 2013. Reportable transfers include consulting fees, honoraria, gifts, entertainment, food, travel, education, research funding, royalties, and grants. The statute enforces the reporting with civil monetary penalties: 1,000 to 10,000 dollars for each unreported payment, capped at 150,000 dollars per year, rising to 10,000 to 100,000 dollars per payment with a 1,000,000-dollar annual cap for knowing failures.

The statute set de minimis thresholds so that trivial transfers escaped reporting: payments of less than 10 dollars per item and less than 100 dollars in aggregate in a year, both subject to an inflation escalator. It also exempted educational materials that directly benefited patients, short-term loans of devices for evaluation, and items covered by warranty. Physicians were given the right to review the data reported about them and to challenge entries they viewed as inaccurate before the information went public.

The provision had a long bipartisan prehistory. Senators Chuck Grassley of Iowa and Herb Kohl of Wisconsin first introduced the Physician Payments Sunshine Act in 2007 and reintroduced it as S. 301 in 2009. Grassley argued that disclosure would hold the medical system accountable and build public confidence in medical research and practice, a position he stated in connection with a 2009 Institute of Medicine report on conflicts of interest in medicine. The sponsors’ case was that transparency would deter financial arrangements that could distort prescribing decisions and that patients deserved to know when their physician had a financial relationship with the maker of a prescribed product. Industry groups negotiated the provision’s terms rather than opposing it outright: the Pharmaceutical Research and Manufacturers of America and the device trade association AdvaMed voiced support for the earlier Senate bill while pressing their concerns about compliance.

Section 4205 amended sections 403 and 403A of the Federal Food, Drug, and Cosmetic Act to require nutrition labeling far beyond the grocery aisle. Chain restaurants and similar retail food establishments with 20 or more locations must post the calorie count of each standard menu item on menus and menu boards, make written nutrition information available on request, and state prominently that the information is available. Operators of 20 or more vending machines must post the calorie count of each food item on a sign in close proximity to the item or its selection button. The Food and Drug Administration’s commissioner, Margaret Hamburg, said in 2010 that giving Americans basic facts about restaurant and vending-machine food would help them make choices that were best for themselves and their families.

Supporters of the provision argued that a single federal standard was preferable to a patchwork of state and local rules and that calorie information at the point of decision could shift eating habits. The compliance estimates were contested. The Food and Drug Administration estimated initial compliance costs of 315 million dollars with ongoing annual costs of about 44 million dollars, while food industry groups put total costs closer to 1 billion dollars. The provision also carried an enforcement wrinkle: parts of the requirement took effect upon enactment, but the agency still had to write the rules defining key terms and measurement standards before the mandate could be fully enforced.

The provision also preempted state and local menu-labeling requirements for covered establishments, replacing the emerging patchwork of city and state rules with a single federal standard.

Section 10907 of the act, codified as section 5000B of the Internal Revenue Code, imposed a 10 percent excise tax on indoor tanning services, defined as services employing electronic products with ultraviolet lamps intended to induce skin tanning. The tax applies to services performed on or after July 1, 2010, and it excludes phototherapy performed by a licensed medical professional. The provision arrived by substitution. The Senate’s original bill had proposed a tax on elective cosmetic medical procedures under section 9017, and the tanning tax replaced it, with section 9017 deemed null and of no effect. The Joint Committee on Taxation, Congress’s nonpartisan revenue estimator, estimated the tax would raise about 200 million dollars in fiscal year 2011.

The tax is paid by the individual on whom the service is performed. The person receiving payment for the service collects the tax from the customer and remits it quarterly to the Treasury, and if the tax is not collected at the time of payment, the person performing the service bears secondary liability for it.

Section 4002 created the Prevention and Public Health Fund, administered through the Office of the Secretary of Health and Human Services. The statute stated the fund’s purpose as providing expanded and sustained national investment in prevention and public health programs to improve health and help restrain the growth of health care costs. As enacted, Congress appropriated 500 million dollars for fiscal year 2010, 750 million for fiscal year 2011, 1 billion for fiscal year 2012, 1.25 billion for fiscal year 2013, 1.5 billion for fiscal year 2014, and 2 billion for fiscal year 2015 and each year thereafter. The Secretary was directed to transfer fund money to department accounts to increase funding, above fiscal year 2008 levels, for prevention, wellness, and public health activities authorized by the Public Health Service Act, including prevention research, health screenings, community transformation grants, and immunization programs.

The statute also gave the appropriations committees of both chambers authority to transfer fund money to eligible activities, and it required that fund dollars supplement, not replace, the fiscal year 2008 funding level for the covered public health programs.

The act’s workforce provisions addressed the supply and training of clinicians. The law established the Community Health Center Fund with 11 billion dollars in appropriations over fiscal years 2011 through 2015 to support health centers and the National Health Service Corps, and it directed 1.5 billion dollars to the Corps itself. The Corps awards scholarships and loan repayment to clinicians who agree to practice in medically underserved areas, a mechanism the law’s authors presented as the workforce complement to the coverage expansion: newly insured patients would need clinicians to treat them.

Early estimates suggested the health center funding could allow the centers to roughly double the number of patients they served, reaching an estimated 20 million more individuals.

Taken together, these provisions show how much of the statute had nothing to do with insurance. A law remembered as health insurance reform rewrote the approval pathway for the most complex medicines, put calorie counts on fast-food menus and vending machines, forced public disclosure of industry payments to physicians, taxed tanning beds, created a permanent fund for prevention, and directed billions of dollars to the clinical workforce. The insurance titles were the public face of the law. The provisions above were its long tail, and they touched drug regulation, food labeling, tax law, and medical ethics without any connection to who bought coverage.

The Exchanges Fallacy: What the Act Is Not

The most common description of the Affordable Care Act is that it is an exchange law. In this description, the statute builds marketplaces where individuals and small businesses shop for health insurance, attaches subsidies to the plans sold there, and thereby solves the problem of the uninsured. The description is not fabricated. Title I of the act does create American Health Benefit Exchanges in every state, with a Small Business Health Options Program alongside them, and it does link premium tax credits and cost-sharing reductions to coverage purchased through those exchanges. The error lies in treating one machine in a five-machine statute as the statute itself.

The picture survives because it is the most visible part of the law. Exchange open enrollment is a news event; a Medicare payment rule is not. Television coverage follows the shopper, not the hospital administrator or the tax adviser, so the public learns the name of the machine it can see. Visibility, however, is not structure. A statute must be judged by its operative provisions, and by that measure the exchange machine is one part among five, flanked by machines that move more people and more money.

The statute’s own structure defeats the description at three points. The first is the Medicaid expansion. Title II extends Medicaid eligibility to adults with incomes up to 133 percent of the federal poverty level, with a 5 percent income disregard that makes the effective line 138 percent, and it adds a maintenance-of-effort requirement barring states from tightening eligibility while the expansion phases in. The Congressional Budget Office estimated that by 2019 the Medicaid and Children’s Health Insurance Program rolls would grow by roughly 16 million people, the largest addition of previously uninsured people to any single coverage source in the enacted design. A statute whose biggest coverage machine is a public insurance program is not, in its operative content, a marketplace law.

The second point is employer coverage. Most insured Americans get their coverage through an employer, and that coverage is governed not by the exchange provisions but by the insurance-rule machine in Title I. The market rules apply across the private market: insurers may not deny coverage or charge higher premiums based on pre-existing conditions, lifetime limits on essential benefits are prohibited, dependent coverage must extend to age 26, and recommended preventive services must be covered without cost sharing. These provisions reach the employer plans that cover the majority of insured Americans. The exchanges serve the individual and small-group markets. The insurance rules touch nearly everyone with private coverage. A reader who equates the act with the exchanges will miss the provisions that affect the most people.

The third point is the delivery title. Title III rewrites how Medicare pays for care, and it touches every Medicare provider in the country. Hospital value-based purchasing ties a share of hospital payments to measured quality. The readmissions program reduces payments to hospitals with excess avoidable readmissions. Accountable care organizations let groups of providers share in savings when they hold spending below a benchmark while meeting quality standards. Pilot programs test bundled payments for episodes of care. None of this involves an exchange, a subsidy, or an individual shopper. The act performs payment-system engineering on the federal government’s largest health program inside the same statute that builds insurance marketplaces, and the two projects share almost nothing except the public law number.

The numbers sharpen the point. The Congressional Budget Office projected that roughly 25 million people would obtain coverage through the exchanges by 2019, a large figure that still leaves the exchanges as one machine among five, serving a fraction of the insured population. Meanwhile the insurance-rule machine governs the employer market covering roughly 160 million people, and the Medicaid machine adds roughly 16 million to public rolls. The exchange machine is real, and for the individual market it is the central fact, but the statute’s own scorekeepers never described it as the statute’s center of gravity.

Because the description and the structure disagree, the question of what the act is deserves a disciplined hearing, and discipline requires giving each contested side its strongest case before any verdict is stated. The two named positions are the ones the act’s own participants took during the 2010 debate.

The supporters’ strongest case is that the act built on private insurance markets rather than replacing them. President Barack Obama argued that the legislation kept the existing system and repaired it: the exchanges are organized marketplaces for private health plans, the premium tax credits subsidize private premiums, employers keep offering coverage, and Medicare continues to operate through existing providers under new payment rules. Named congressional sponsors made the same structural point. Senate Finance Committee Chairman Max Baucus, who guided the legislation through the Senate, presented it as reform anchored in private insurers, private employers, and private markets, with new federal rules but not federal provision of care. A year after enactment, Baucus pointed to small-business tax credits for firms offering coverage, the end of coverage denials for children with pre-existing conditions, and a Congressional Budget Office estimate that the law would reduce the deficit by 143 billion dollars over its first decade, presenting the statute as fiscally responsible reform built on private coverage. On this reading, the exchanges are not the whole statute, but they are its public face, the mechanism through which the law’s philosophy of market-based coverage expansion is expressed.

The opponents’ strongest case is that the act represented an excessive federal role in health care. House Minority Leader John Boehner and Senate Minority Leader Mitch McConnell argued during the 2010 debate that the federal government was reaching too far into decisions that belonged to individuals and states: the individual responsibility requirement compels Americans to purchase a product whose terms the federal government defines, the statute sets essential health benefits and market rules for plans in every state, and the Medicaid expansion, as enacted with maintenance-of-effort provisions, constrains state budgets from Washington. McConnell made the federalism version of the same point in the Senate, arguing that the Medicaid expansion and the federal benefit mandates displaced state decisions about insurance markets and public budgets. On this reading, the federal rules are the real law, and the exchanges are a market veneer over federal control of insurance regulation.

The supported verdict concerns the statute as text, and it makes no claim about whether the law is good policy. Both readings above agree, without noticing it, that the act is one thing: a marketplace law to its defenders, a federal power grab to its critics. The statute refuses to be one thing. Its ten titles contain an insurance-rule machine, an exchange and subsidy machine, a Medicaid machine, a delivery-reform machine, and a financing machine, plus non-insurance titles covering prevention and wellness, the health workforce, program integrity, the reauthorization of the Indian Health Care Improvement Act, and technical amendments to the other titles. The popular description (a marketplace law) and the operative content (a five-machine statute plus non-insurance titles) are different objects. A reader who learns the text will not mistake one for the other, because the text is a statute, and a statute is a set of machines whose parts do different work on different populations. The verdict does not rank the machines by importance, because importance is a policy question; it only holds that the machines are distinct, and that a description which names one of them names a part, not the whole.

Why the Statute Matters More Than Its Description

This series proceeds from a thesis: a statute’s popular description and its operative content are frequently different objects, and the Affordable Care Act is the strongest case the series has for that thesis. The reason is not that the popular description is dishonest. It is that a description must compress, and compression discards the distinctions a statute is built from. The act’s description says it is a health reform program that covers the uninsured through marketplaces. Its content is a set of legal machines that impose duties on different actors, move different money, and answer to different professionals. The description and the content diverge not in emphasis but in kind.

Each machine answers a different professional question, and that is the clearest proof that the act is a statute rather than a program. A benefits lawyer reads the insurance-rule machine in Title I, because it rewrites the terms on which private plans may operate: guaranteed issue, modified community rating, the ban on pre-existing condition exclusions, the medical loss ratio rules, the internal and external appeals requirements, and the grandfathering provisions that decide which existing plans keep their old rules. That lawyer never needs to visit an exchange to do her work, because the exchange provisions govern distribution while the insurance rules govern the product itself.

A tax adviser reads the financing machine in Title IX, because it is a tax statute wearing a health statute’s clothes. It imposes an additional Hospital Insurance tax on the wages of high earners, adds a Medicare contribution on unearned income, levies annual fees on health insurers and on manufacturers and importers of branded prescription drugs, imposes an excise tax on medical devices, creates the excise tax on high-cost employer-sponsored plans, and establishes the individual and employer responsibility payments. The tax adviser’s client may be an insurer, a manufacturer, or an individual, but the questions are revenue questions: who pays, how much, and when. Nothing about that work resembles shopping for insurance.

A hospital administrator reads the delivery machine in Title III, because it changes how her institution gets paid. Value-based purchasing, readmissions penalties, accountable care organizations, bundled-payment pilots, the Hospital-Acquired Condition program, and the Independent Payment Advisory Board all operate inside Medicare, and they reach every provider that bills the program. The administrator’s question is operational: which quality measures move revenue, and which care pathways keep the institution inside its benchmarks. The exchange machine cannot answer that question, and the financing machine cannot answer it either.

Two more readers complete the map. A state Medicaid official reads the Medicaid machine in Title II, because the expansion, the maintenance-of-effort rules, and the changes to the Children’s Health Insurance Program determine who her agency must cover and what share the federal government will pay. A tribal health director reads Title X, which reauthorizes the Indian Health Care Improvement Act and modernizes the Indian health system. Neither of them is studying a marketplace, and neither would recognize their work in the popular description of the law.

The frame extends beyond the five machines’ home professions. A pharmaceutical executive reads Title VII, where the biosimilars pathway decides how soon a follow-on biologic can reach the market and at what price. A restaurant chain’s counsel reads the menu-labeling provisions in Title IV, which impose calorie disclosure duties on large chains. A long-term care planner reads Title VIII. Each of these readers is reading the Affordable Care Act, and each would be baffled by a description of the law that mentions only marketplaces, because the provisions that govern their clients’ conduct have nothing to do with exchanges.

Treating the act as a policy program instead of a statute is the source of most confusion about it. A program has a single purpose and a single audience, so program thinking asks one question: does it work. A statute has many purposes and many audiences, so statute thinking asks many questions: what duty does this section impose, on whom, enforced by what mechanism, paid for by what revenue. When commentators debate the program, they flatten the machines into a single verdict, and provisions that do not fit the verdict disappear from the discussion. The biosimilars pathway in Title VII, which creates an abbreviated approval route for follow-on biologic drugs, affects the pharmaceutical market for a generation, yet it never appears in program-level debate because it is not about coverage. The Community Living Assistance Services and Supports program in Title VIII creates a voluntary long-term care insurance framework, yet it vanishes from the same debate for the same reason.

The statute repays the reader who treats it as a statute. Each machine has its own logic, its own enforcement mechanism, and its own constituency, and each can be understood on its own terms before the reader asks how the machines fit together. That is why the statute matters more than its description: the description compresses the law into a slogan, while the statute tells you what the law does, to whom, and at whose expense. That discipline is also the only honest way to argue about the law. Two people can disagree about the insurance rules while agreeing about the delivery reforms, because the statute lets its parts be judged separately. Program thinking forces a single verdict on roughly 2,700 pages; statute thinking permits the reader to assess each machine on its own terms, section by section.

How to Study This Statute

The five-machine map is a study tool, and it works best when the reader uses it to divide the statute into manageable parts. Begin by naming the machine before reading its provisions: insurance rules, exchanges and subsidies, Medicaid, delivery reform, and financing, plus the non-insurance titles as a separate shelf for prevention, workforce, program integrity, and the Indian Health Care Improvement Act. A reader who can say which machine a section belongs to will stop confusing the parts with each other, which is the most common beginner error with this law.

The map also corrects the errors beginners make. The most common is the exchanges fallacy itself: assuming the whole law is the marketplace provisions. The second is treating the two statutes as rivals, when Public Law 111-152 only amends Public Law 111-148. The third is reading the revenue title as an afterthought, when Title IX is the machine that pays for the other four. A student who checks each provision against the map before deciding what it means will avoid all three errors, because the map forces the question the beginner skips: which machine is this section part of, and whose conduct does it govern?

Read the act title by title rather than straight through. The Congressional Research Service describes the law as comprising ten titles, with Titles I through VIII addressing how health care is financed, organized, and delivered, Title IX containing the revenue provisions, and Title X reauthorizing the Indian Health Care Improvement Act and amending the other nine titles. That order is a study order: start with Title I to learn the market rules, then Title II for Medicaid, then Title III for delivery, then Title IX for financing, and use Title X last as a set of amendments that only make sense once the provisions they amend are understood.

Learn the section-numbering convention before the substance. Sections are numbered within titles, so section 1302 sits in Title I and section 3022 sits in Title III, and a reader who learns to read the first two digits as the title will navigate the statute’s roughly 2,700 pages without getting lost. The guide at how to read a federal statute explains these numbering habits in general terms, and applying them to this act turns the page count from an obstacle into an index.

Use the companion study notebook to drill the machines. The VaultBook legislation study notebook is built for exactly this exercise: take one machine at a time, list its operative sections, state each section’s duty and its enforcement mechanism in one sentence, and test whether you can place any provision in its machine without looking. A student who can do that for all five machines plus the non-insurance titles knows the statute’s structure, and structure is what survives when details fade.

Finally, place the act in its sequence. US health legislation since 1950 shows where this statute sits among the laws that came before it, from the creation of Medicare and Medicaid through the Health Insurance Portability and Accountability Act to the Medicare prescription drug law, and reading the sequence teaches what problem each generation of legislation was answering. The sequence also explains the statute’s size: each generation of health legislation since 1950 has added a layer without repealing the last, so the Affordable Care Act amends the Public Health Service Act, the Social Security Act, the Internal Revenue Code, and the Employee Retirement Income Security Act rather than replacing them. Knowing the sequence teaches the reader why the statute is an overlay on older laws instead of a fresh start. When the five machines are mastered and the sequence is understood, the next question is what to study next, and the US legislation study guide helps readers choose their next statute with the same title-by-title method.

What is the fastest way to get oriented in the Affordable Care Act?

Read the table of contents first, then assign every provision you meet to one of the five machines: insurance rules, exchanges and subsidies, Medicaid, delivery reform, or financing, with non-insurance titles on a separate shelf. A reader who can place each section in its machine within a week has the statute’s structure, and that structure is the fastest orientation.

Frequently Asked Questions

Q: What is the Affordable Care Act in simple terms?

In simple terms, it is a 2010 federal law that rewrites the rules of American health insurance and health care payment. Its core bargain, as its sponsors described it, pairs new duties with new support: insurers must cover people regardless of pre-existing conditions and meet federal benefit and pricing rules, while most individuals must carry qualifying coverage, with tax credits for those who cannot afford it. States expand Medicaid to more low-income adults as enacted, with federal funding, and Medicare begins paying providers partly on quality and efficiency rather than volume alone. The law’s ten titles span insurance markets, Medicaid, Medicare delivery reform, taxes, and subjects as far afield as drug approvals and the Indian health system.

Q: Is Obamacare the same thing as the Affordable Care Act?

Yes. Obamacare is the common informal name for the Patient Protection and Affordable Care Act, and both terms refer to the same statute, Public Law 111-148 as amended by Public Law 111-152. Supporters and opponents both used the informal name during the 2010 debate, and neither usage changes the law’s content. In neutral writing the formal short title, Affordable Care Act or ACA, is preferred because it names the law rather than a political brand. This guide uses both terms only so that readers who arrive searching under either name can find the same statute and study the same text.

Q: Which president signed the Affordable Care Act?

President Barack Obama signed the Patient Protection and Affordable Care Act, Public Law 111-148, on March 23, 2010, after the Senate passed the bill on December 24, 2009 and the House passed it on March 21, 2010. One week later, on March 30, 2010, he signed the companion Health Care and Education Reconciliation Act, Public Law 111-152, which amended the first statute. The two signings a week apart are the reason the law is sometimes described as one statute and sometimes as two, and both descriptions trace to the same presidential signature.

Q: What is the public law number of the Affordable Care Act?

The Affordable Care Act is Public Law 111-148, cited as 124 Stat. 119, enacted by the 111th Congress. Its companion measure, the Health Care and Education Reconciliation Act, is Public Law 111-152, cited as 124 Stat. 1029. When legal writers cite the law as amended, they generally cite Public Law 111-148 as amended by Public Law 111-152, because the reconciliation act modified the original statute’s coverage, Medicare, Medicaid, and revenue provisions rather than standing as an independent health law. Both citations appear together in most legal writing on the statute.

Q: Is the Affordable Care Act one law or two?

It is two statutes that are read as one law. The Patient Protection and Affordable Care Act, Public Law 111-148, was signed on March 23, 2010, and the Health Care and Education Reconciliation Act, Public Law 111-152, was signed on March 30, 2010. The second statute amended multiple health care and revenue provisions of the first, and the Congressional Research Service treats the two together as the health reform law. A student who reads only Public Law 111-148 will miss the reconciliation amendments to subsidies, Medicaid matching, and taxes, so both texts belong in any serious study of the statute.

Q: What problem was the Affordable Care Act meant to solve?

Its sponsors described the problem as a coverage crisis combined with a cost crisis. Census Bureau figures showed more than 46 million Americans without health insurance, and sponsors pointed to medical underwriting that let insurers deny coverage or charge unaffordable premiums based on pre-existing conditions. They also cited rapidly rising premiums that were straining family budgets and employer payrolls, and Medicare spending growth that threatened the program’s finances. The statute answers each part with a different machine: insurance rules for underwriting, subsidies and Medicaid for the uninsured, and delivery reforms for cost growth.

Q: What is a short summary of the Affordable Care Act?

The Affordable Care Act is a ten-title federal statute enacted in March 2010 that restructures American health insurance and health care payment. Title I sets federal rules for private insurance markets and creates exchanges with premium subsidies. Title II expands Medicaid as enacted. Title III reforms how Medicare pays providers, emphasizing quality and efficiency. Title IX raises the revenue to pay for the coverage expansion through taxes and fees. The remaining titles address prevention, the health workforce, fraud enforcement, drug approvals, long-term care insurance, and the reauthorization of the Indian Health Care Improvement Act.

Q: Where is the Affordable Care Act in the US Code?

It has no single home in the United States Code. The statute amends the Public Health Service Act in title 42, the Internal Revenue Code in title 26, the Employee Retirement Income Security Act in title 29, and the Medicare and Medicaid provisions of the Social Security Act in title 42, while adding freestanding sections that had no prior codified home. The Congressional Research Service has noted that identifying every affected provision is difficult because of the number of provisions, their complexity, and their spread across the Code. A student looking for the law should start with the public law text, not the Code.

Q: What are the five machines of the Affordable Care Act?

The five machines are the statute’s five functional cores. The insurance-rule machine in Title I sets the market rules for private plans, including guaranteed issue and benefit standards. The exchange and subsidy machine, also in Title I, creates the marketplaces and the premium tax credits. The Medicaid machine in Title II expands public coverage as enacted. The delivery-reform machine in Title III changes how Medicare pays providers. The financing machine in Title IX raises revenue through taxes, fees, and responsibility payments. The non-insurance titles sit on a separate shelf, covering prevention, workforce, fraud, drug approvals, and Indian health.

Q: Which taxes and fees pay for the Affordable Care Act?

Title IX, the revenue title, spreads the financing across several sources. It adds a 0.9 percent Hospital Insurance tax on the wages of high earners and a 3.8 percent Medicare contribution on unearned income. It levies annual fees on health insurers and on manufacturers and importers of branded prescription drugs, imposes an excise tax on medical devices, and creates the excise tax on high-cost employer-sponsored plans. It also establishes the individual and employer responsibility payments. The Congressional Budget Office and the Joint Committee on Taxation scored these provisions together with the spending provisions when they estimated the law’s budgetary effect.

Q: How does the Affordable Care Act expand Medicaid?

As enacted, Title II extends Medicaid eligibility to adults with incomes up to 133 percent of the federal poverty level, with a 5 percent income disregard that makes the effective threshold 138 percent. It bars states from tightening eligibility standards while the expansion phases in, through maintenance-of-effort requirements, and it provides enhanced federal matching funds for the newly eligible population. The Congressional Budget Office estimated that the Medicaid and Children’s Health Insurance Program rolls would grow by roughly 16 million people by 2019, the largest addition of previously uninsured people to any single coverage source in the enacted design.

Q: What Medicare delivery reforms does the Affordable Care Act include?

Title III contains the delivery reforms, and they reach every provider that bills Medicare. Hospital value-based purchasing ties a share of payments to measured quality. The readmissions program reduces payments to hospitals with excess avoidable readmissions. Accountable care organizations, created in section 3022, let groups of providers share savings when they hold spending below a benchmark while meeting quality standards. Pilot programs test bundled payments for episodes of care. The title also creates the Hospital-Acquired Condition program and the Independent Payment Advisory Board as enacted. None of these provisions depends on the insurance exchanges.

Q: What non-insurance provisions does the Affordable Care Act contain?

The non-insurance titles reach well beyond coverage. Title IV funds prevention and wellness, including the Prevention and Public Health Fund and menu-labeling requirements for chain restaurants. Title V addresses the health care workforce through training and recruitment programs. Title VI strengthens program integrity and fraud enforcement. Title VII creates an abbreviated approval pathway for biosimilar biologic drugs. Title VIII establishes the Community Living Assistance Services and Supports program, a voluntary long-term care insurance framework. Title X reauthorizes the Indian Health Care Improvement Act, modernizing the Indian health system. These provisions show why the marketplace description misses so much of the statute.

Q: What did the Health Care and Education Reconciliation Act change in the Affordable Care Act?

The Health Care and Education Reconciliation Act, Public Law 111-152, signed March 30, 2010, amended the Affordable Care Act’s coverage, Medicare, Medicaid, and revenue provisions rather than creating a separate health law. Its health title increased the generosity of the premium tax credits, modified the excise tax on high-cost employer plans after negotiations with labor unions, adjusted Medicaid matching provisions, and added revenue measures including the Medicare contribution on unearned income. Its education title ended the bank-based student loan program in favor of direct federal lending. The two statutes are read together as the health reform law.

Q: Does the Affordable Care Act replace employer-sponsored health insurance?

No. The act preserves the employer-based system and regulates it rather than replacing it. Title I’s insurance market rules apply to employer plans: the ban on pre-existing condition exclusions, the prohibition on lifetime limits, dependent coverage to age 26, and preventive services without cost sharing all reach workers covered through their jobs. The statute adds an employer responsibility requirement for large employers as enacted, alongside the individual requirement. The Congressional Budget Office projected that employer coverage would remain roughly stable, with most insured Americans continuing to get coverage through work.

Q: What is the individual responsibility requirement?

As enacted, the individual responsibility requirement provides that most Americans must maintain minimum essential health coverage or pay a penalty with their federal taxes. The penalty phases in over several years and is the greater of a flat dollar amount or a percentage of household income above the filing threshold. The statute exempts people with unaffordable coverage options, members of recognized religious sects with objections to insurance, and those facing hardship, among other categories. Sponsors described the requirement as the mechanism that makes guaranteed issue workable, since insurers cannot be required to cover everyone regardless of health status if healthy people may wait until they are sick to enroll.

Q: What are the health insurance exchanges created by the Affordable Care Act?

The exchanges are state-based marketplaces, called American Health Benefit Exchanges, where individuals and small businesses can compare and purchase qualified health plans, with a Small Business Health Options Program for employers. A state may run its own exchange or decline, in which case the federal government operates one in that state. Plans sold on the exchanges must meet federal benefit and cost-sharing standards and are grouped into metal tiers of bronze, silver, gold, and platinum by actuarial value. Premium tax credits for households between 100 and 400 percent of the poverty level, and cost-sharing reductions for lower-income enrollees, are available only for coverage purchased through an exchange.

Q: What did the Affordable Care Act change about pre-existing conditions?

Title I effectively ends medical underwriting in the individual and small-group markets. Insurers must offer coverage to every applicant, a rule called guaranteed issue, and may not exclude or limit benefits for pre-existing conditions. Premiums may vary only by age, tobacco use, geography, and family size, a rule called modified community rating, so health status can no longer drive pricing. The statute also bans rescissions, the practice of canceling coverage retroactively when a policyholder gets sick, except in cases of fraud or intentional misrepresentation. The protections for children took effect in 2010, with the full rules applying to all enrollees beginning in 2014.

Q: How is the Affordable Care Act organized into titles?

The Congressional Research Service describes the law as comprising ten titles. Title I covers private health insurance, including market rules, exchanges, and subsidies. Title II covers Medicaid and the Children’s Health Insurance Program. Title III addresses Medicare delivery and payment reform. Title IV covers prevention and wellness. Title V covers the health care workforce. Title VI covers program integrity, fraud, and transparency. Title VII covers drug and biologic approvals. Title VIII creates the long-term care insurance program. Title IX contains the revenue provisions. Title X reauthorizes the Indian Health Care Improvement Act and amends provisions in the other nine titles.

Q: How should a student study the Affordable Care Act title by title?

Start with the ten-title table of contents and assign every provision to one of the five machines: insurance rules, exchanges and subsidies, Medicaid, delivery reform, or financing, with non-insurance provisions on a separate shelf. Read Title I for the market rules, Title II for Medicaid, Title III for delivery, and Title IX for financing before touching Title X, which amends the other titles and only makes sense afterward. For each section, write one sentence stating its duty, the actor bound, and the enforcement mechanism. A companion study notebook that drills this placement exercise will test whether the structure has been learned.